Ryan Henrici, M.D., Ph.D.

Vice President, Discovery Medicine at BigHat Biosciences

Speaker

Dr. Henrici is the Vice President, Discovery Medicine at BigHat Biosciences, a Series B stage biotechnology company. At BigHat, he leads the development of the internal therapeutics pipeline supports therapeutic target identification, early antibody discovery, and lead optimization through in vivo assessment of efficacy and safety in models of human cancers and rare diseases. His team specializes in leveraging machine learning and synthetic biology methods to design next-generation therapeutic antibodies, such as multi-specifics, immune engagers, conditionally active antibodies, and antibody-drug conjugates, among other difficult-to-engineer modalities. He trained as a physician-scientist, earning his MD from University of Pennsylvania and PhD in Infectious and Tropical Diseases from the London School of Hygiene & Tropical Medicine.